Just one or two experiences with marijuana may alter teen brains

Agencies
January 16, 2019

Jan 16: Teens who use pot just one or two times may end up with changes to their brains, a new study finds.

There were clear differences on brain scans between teens who said they had tried cannabis a couple of times and those who completely eschewed the drug, researchers reported in the Journal of Neuroscience.

There have been hints that even small amounts of pot at a young age might impact the brain, said the study’s lead author, Catherine Orr, a lecturer at the Swinburne University of Technology in Melbourne, Australia. “Research using animals to study the effects of cannabis on the brain have shown effects at very low levels, so we had reason to believe that brain changes might occur at even the earliest stages of cannabis use,” Orr said in an email.

Still, she said, “I was surprised by the extent of the effects.”

With an estimated 35 percent of U.S. teens using cannabis, the new findings are concerning, the researchers noted.

Orr and her colleagues saw widespread increases in the volume of grey matter in brain regions that are rich with cannabinoid receptors. Grey matter, which is made up of nerve cell bodies, is involved in sensory perception and muscle control.

To take a closer look at the impact of mild marijuana use in developing brains, Orr’s team analyzed brain scans gathered as part of the larger IMAGEN study, which was designed to look into adolescent brain development.

The researchers analyzed images from 46 14-year-olds who said they had used marijuana once or twice, as well as images from 46 non-cannabis using teens matched “on age, sex, handedness, pubertal status, IQ, socioeconomic status, and use of alcohol and tobacco,” Orr said.

The researchers spotted clear differences between the two groups, which they suspect are due to the low-level pot use. They acknowledge that the study didn’t actually prove that marijuana led to the differences seen in the scans. It’s possible that those who chose to use weed were different to begin with and that the marijuana hadn’t played a role in brain development.

To try to address this question, the researchers analyzed scans from a third group of teens who had not tried marijuana before they had their brain scans at age 14. By age 16, 69 of these kids said they had used marijuana at least 10 times. But their brain scans at age 14 looked no different than brain scans of other kids who had not taken up cannabis by age 16 - which meant there wasn’t any inborn brain difference that would have predicted who would later become a pot user.

There may be serious implications to the brain changes noted by the researchers. “In our sample of cannabis users, the greater volumes in the affected parts of the brain were associated with reductions in psychomotor sped and perceptual reasoning and with increased levels of anxiety two years later,” Orr said.

The reason for the higher volume of grey matter in cannabinoid-rich regions of the brain may be related to a normal process called “pruning” which may go awry when kids use marijuana, Orr said. As young brains develop, unnecessary or defective neurons are pruned away, she explained. When the system doesn’t work correctly, those cells remain in place.

The new findings are a step toward understanding the impact of cannabis on young brains, said Dr. Michael Lynch, a toxicologist and emergency medicine physician and director of the Pittsburgh Poison Center at the University of Pittsburgh Medical Center. “It’s important that there was a change,” Lynch said. “Adolescent brains are going to be more vulnerable to anything drug or environmentally related.”

If pruning isn’t working right, “the brain may not work as efficiently as it should,” Lynch said. “But I don’t think we can make a final determination on that from this study.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 30,2020

New York, Jul 30: Can the coronavirus spread through the air? Yes, it's possible.

The World Health Organisation recently acknowledged the possibility that Covid-19 might be spread in the air under certain conditions.

Recent Covid-19 outbreaks in crowded indoor settings — restaurants, nightclubs and choir practices — suggest the virus can hang around in the air long enough to potentially infect others if social distancing measures are not strictly enforced.

Experts say the lack of ventilation in these situations is thought to have contributed to spread, and might have allowed the virus to linger in the air longer than normal.

In a report published in May, researchers found that talking produced respiratory droplets that could remain in the air in a closed environment for about eight to 14 minutes.

The WHO says those most at risk from airborne spread are doctors and nurses who perform specialized procedures such as inserting a breathing tube or putting patients on a ventilator.

Medical authorities recommend the use of protective masks and other equipment when doing such procedures.

Scientists maintain it's far less risky to be outside than indoors because virus droplets disperse in the fresh air, reducing the chances of Covid-19 transmission.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 4,2020

The Union health ministry on Friday revised the dosage of anti-viral drug remdesivir to be administered to coronavirus patients in the moderate stage of illness from the earlier six days to five days as it issued an updated 'Clinical Management Protocols for COVID-19'.

The drug, administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for four days (total five days), the new treatment protocols stated.

The Health Ministry on June 13 had allowed the use of remdesivir for restricted emergency use in moderate cases under "investigational therapies".

"Under emergency use authorisation, remdesivir may be considered for patients in moderate stage requiring oxygen support," the document stated.

It is not recommended for those with severe renal impairment and high level of liver enzymes, pregnant and lactating women, and those below 12 years, it said.

The ministry also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma for treating COVID-19 patients in the moderate stage of illness as "investigational therapies".

It also recommended hydroxychloroquine for patients during the early course of the disease and not for critically-ill patients.

On June 27, the ministry had included an inexpensive, widely used steroid dexamethasone in treatment protocols for COVID-19 patients in the moderate to severe stages of their illness among other therapeutic measures.

The ministry advised use of dexamethasone, which is already used in a wide range of conditions for its anti-inflammatory and immunosuppressant effects, as an alternative choice to methylprednisolone for managing moderate to severe cases of coronavirus infection.

India's COVID-19 cases soared by over 20,000 in a day for the first time taking the country's total tally to 6,25,544 on Friday while the death toll climbed to 18,213 with 379 new fatalities, according to the Union Health Ministry data updated at 8 am.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 25,2020

Washington D.C., Jan 25: A new study conducted by a team of researchers reveals why individuals who have a history of early life adversity (ELA) are disproportionately prone to opioid addiction.

The study conducted examined how early adversities interact with factors such as increased access to opioids to directly influence brain development and function, causing a higher potential for opioid addiction.

The study was lead by UCI researchers and was published in Molecular Psychiatry.

Tallie Z. Baram, MD, PhD, the Danette Shepard Chair in Neurological Sciences at the UCI School of Medicine and one of the senior researchers for the study, was on the take that the widely known factor genetics that plays major role in addiction vulnerability, cannot be solely held responsible for the recent rise in opioid abuse.

To further clarify, the researchers simulated ELA in rats by limiting bedding and nesting materials during a short, postnatal period of time.

In female rats, this led to striking opioid addiction-like characteristics including an increased relapse- behaviour, for example.

As observed in addicted humans, the rats were willing to work very hard (pay a very high price) to obtain the drug.

Baram said: "Ultimately, we found that conditions during sensitive developmental periods can lead to vulnerability to the addictive effects of opioid drugs, especially in females, which is consistent with the prevalence of ELA in heroin-addicted women."

These findings can be used to highlight the importance given to sex differences in future ELA-related studies on opioid addiction, and in future prevention or intervention strategies being developed to address the growing opioid crisis.

The study conducted examined how early adversities interact with factors such as increased access to opioids to directly influence brain development and function, causing a higher potential for opioid addiction.

The study was lead by UCI researchers and was published in Molecular Psychiatry.

The study found that unpredictable, fragmented early life environments may lead to abnormal maturation of certain brain circuits, which profoundly impacts brain function and persists into adolescence and adulthood.

Tallie Z. Baram, MD, PhD, the Danette Shepard Chair in Neurological Sciences at the UCI School of Medicine and one of the senior researchers for the study, was on the take that the widely known factor genetics that plays major role in addiction vulnerability, cannot be solely held responsible for the recent rise in opioid abuse.

To further clarify, the researchers implanted ELA in rats by limiting bedding and nesting materials during a short, postnatal period of time.

In female rats, this led to striking opioid addiction-like characteristics including an increased relapse- behaviour, for example.

As observed in addicted humans, the rats were willing to work very hard (pay a very high price) to obtain the drug.

Baram said: "Ultimately, we found that conditions during sensitive developmental periods can lead to vulnerability to the addictive effects of opioid drugs, especially in females, which is consistent with the prevalence of ELA in heroin-addicted women."

These findings can be used to highlight the importance given to sex differences in future ELA-related studies on opioid addiction, and in future prevention or intervention strategies being developed to address the growing opioid crisis.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.